Cargando...
CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial
OBJECTIVE: An investigator-initiated, multicenter, randomized, placebo-controlled, double-blind clinical trial to determine whether coenzyme Q10 (CoQ10) is safe, well tolerated, and effective in slowing functional decline in progressive supranuclear palsy (PSP). METHODS: Sixty-one participants recei...
Guardado en:
| Publicado en: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990260/ https://ncbi.nlm.nih.gov/pubmed/27583276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000266 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|